Indian firm's jab '81-per-cent effective'

By Sunrita Sen
Updated March 4 2021 - 5:44am, first published 5:41am
The Covaxin vaccine was developed with the support of the Indian Council of Medical Research.
The Covaxin vaccine was developed with the support of the Indian Council of Medical Research.

Indian pharmaceutical firm Bharat Biotech says an interim analysis of stage-three trials of its COVID-19 vaccine have shown that it has 81-per-cent efficacy in preventing the disease.

Get the latest Mandurah news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.